Business Wire

Stallergenes Greer and Alyatec Announce Research Collaboration to Advance Precision Medicine in Allergen Immunotherapy

Share

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), and Alyatec, a contract research organisation based in Strasbourg University Hospital (France), today announced that they have entered into a collaboration to advance precision medicine in AIT.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210709005081/en/

With this collaboration, Stallergenes Greer aims to strengthen its precision medicine-based approach and the management of patients with allergies by expanding its knowledge of allergy pathophysiology and endotypes, AIT mode of action and clinical validation.

This research collaboration brings together the longstanding expertise of Stallergenes Greer in AIT and Alyatec’s competencies in research and clinical services as well as its state-of-the-art technology, including a new generation environmental exposure chamber.

“We are excited about the collaboration with Alyatec which will support Stallergenes Greer’s ambition to advance the practice of allergology. With Alyatec and its team of distinguished key opinion leaders, Stallergenes Greer will continue to build on precision medicine and personalised healthcare to significantly improve patient disease outcomes”, declared Amer Jaber, Executive VP Operations Europe and International and President of Stallergenes SAS.

This collaboration is a remarkable opportunity for Alyatec to develop precision medicine in AIT. The field of allergology is the oldest form of precision medicine as patient phenotypes are directly related to specific results provided by skin tests. We are convinced that adapting immunotherapy to the phenotype of each patient, in other words finding the right immunotherapy for the right patient, is the future of AIT,” stated Professor Frédéric de Blay, Principal investigator and Medical expert of Alyatec.

ABOUT ALLERGEN IMMUNOTHERAPY

Allergies are the most prevalent and fastest growing chronic disease in the industrialised world, affecting over one billion people worldwide1. Allergen immunotherapy is an allergy treatment designed to alter the natural course of respiratory allergies by treating the underlying cause of the disease. Allergen extracts are modifying disease by inducing tolerance in the immune system2,3.

ABOUT STALLERGENES GREER

Headquartered in London (UK), Stallergenes Greer Ltd is a global healthcare company specialising in the diagnosis and treatment of allergies through the development and commercialisation of allergy immunotherapy products and services. Stallergenes Greer Ltd is the parent company of Greer Laboratories, Inc. (whose registered office is in the United States) and Stallergenes SAS (whose registered office is in France).

ABOUT ALYATEC

Alyatec is a contract research organisation based in Strasbourg University Hospital (France) which performs clinical studies related to respiratory allergies. Thanks to its specific knowledge and medical expertise Alyatec can evaluate the effect of solutions against asthma, rhinitis and conjunctivitis caused by environmental factors such as cat allergens, pollens and house dust mites. To perform these clinical trials, Alyatec has an environmental exposure chamber which enables the assessment of the mode of action of allergy treatment solutions in an innovative and efficient way. The company provides a full range of clinical services in the area of respiratory allergies with all the benefits related to the use of Alyatec’s allergen exposure unit.

1.World Health organisation, Ambient Air Pollution: Health Impacts
2.Global Atlas of Allergy, EAACI 2014
3.Halken 2017: EAACI guidelines on allergen immunotherapy: Prevention of allergy

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Stallergenes Greer
Catherine Kress
Tel: +33 (0)1 55 50 26 05
Email: catherine.kress@stallergenesgreer.com

Alyatec
Nathalie Domis
Tel: +33(0) 67 68 00 90
Email: Nathalie.Domis@alyatec.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BehavioSec Expands Portfolio and Opens Market Access with Another Industry First29.7.2021 09:00:00 CEST | Press release

BehavioSec, industry pioneer and technology leader for behavioral biometrics and continuous authentication, today announced that it has extended its patented technology and BehavioSense platform into a SOC/ISO compliant, hosted-version and a cloud-native, SaaS version. These new versions will help more organizations meet compliance and cloud mandates, support frictionless multi-factor authentication (MFA), and gain access to the market’s most advanced behavioral biometrics technology – which until now – has only been employed within the world’s largest banks, e-Identity providers, and online retailers. According to the recent July release of the 2021 Gartner ® Market Guide for Online Fraud Detection, “The convergence between online fraud detection (OFD), identity proofing and authentication continues with many organizations applying OFD capabilities to mitigate risk in identity proofing and authentication events.” The report further adds, “Banks are becoming increasingly comfortable wi

SES Enters Multi-transponder Agreement with NewSpace India Limited via SES-829.7.2021 08:58:00 CEST | Press release

SES announced today that it had entered into a multi-transponder agreement for its SES-8 satellite with NewSpace India Limited (NSIL), a Central Public Sector Enterprise (CPSE) under Department of Space (DoS) based in Bengaluru, India. The nine-transponder capacity agreement on SES-8 at 95 degrees East will be used to support India’s thriving direct-to-home (DTH) market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210728006179/en/ SES Enters Multi-transponder Agreement with NewSpace India Limited via SES-8 (Photo: Business Wire) Deepak Mathur, Executive Vice President of Sales at SES Video, said, “Satellite TV and the programmes it brings hold a very important role for Indian TV viewers. We are honoured to be able to provide continued support and satellite capacity needed to support DTH operations in the country in collaboration with NSIL." Follow us on: Read our Blogs > Visit the Media Gallery > About SES SES has a bold

Mekitec Acquires Grupo Bimbo’s AI-Focused Subsidiary29.7.2021 08:15:00 CEST | Press release

Food quality control system manufacturer Mekitec Group acquired Grupo Bimbo subsidiary Kanan Smart Solution on July 15, 2021, including a software development team and local sales and service operations in Mexico. This solidifies Mekitec’s place among the global leaders of X-ray inspection systems for baking companies and boosts the company’s market position throughout Latin America. Grupo Bimbo has used Mekitec’s X-ray systems, powered by Kanan’s software solutions, for many years. Bimbo Ventures, Grupo Bimbo’s venture arm, will now enable Mekitec to grow faster and increase its focus on baking solutions. In food inspection, X-ray systems are considered the most sustainable choice; they minimize waste and maximize traceability without compromising the main purpose, consumer safety. “Traceability and artificial intelligence are significant drivers for the future of food safety,” says Antti Sivula, Mekitec Group’s CEO. “This acquisition is of major strategic importance for Mekitec, enab

iProov Achieves Record-breaking Growth as Demand for Genuine Presence Assurance ™ Soars29.7.2021 06:01:00 CEST | Press release

iProov, world leader in secure biometric authentication technology, today announced record-breaking growth in the first half of 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210728006091/en/ iProov's Genuine Presence Assurance™ technology verifies that an online user is the right person, a real person, authenticating right now. (Photo: Business Wire) From January to June 2021, iProov saw a 15x increase in the number of people verified using its technology versus the same time period last year. Its flagship Genuine Presence Assurance technology solidified its global market leadership, with verifications growing at a consistent rate of 25% per month worldwide. This has been driven by demand from organizations needing to verify the identity of online users to prevent fraud. iProov’s patented technology assures the genuine presence of an online user to ensure they are the right person, a real person, and authenticating ri

Wemade Co., Ltd. Announces Pre-Registration for MIR 4, an Open World K-Fantasy MMORPG29.7.2021 05:00:00 CEST | Press release

“From my battle to our war.” MIR 4, the unique open world K-Fantasy MMORPG, opens for global pre-registration on Thursday, 29 July. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210728006129/en/ Wemade 's MIR 4, the unique open world K-Fantasy MMORPG, opens for global pre-registration on Thursday, 29 July. Pre-registration will be available on MIR 4’s official website, the Google Play Store and the Apple App Store. Pre-registered users will enjoy various in-game items on launch. The game beautifully portrays the mystical and elegant life of the Orient, offering a truly singular experience for MMORPG players across the world. The global version is upgraded from the Korean in that it has adopted blockchain technology. The digital assets in MIR 4 can be made NFT or FT in order to buy, sell or trade for profit. The global release will be available in more than 170 countries on both mobile and PC. (Graphic: Business Wire) The ga

Riskified Ltd. Announces Pricing of Initial Public Offering29.7.2021 01:57:00 CEST | Press release

Riskified Ltd. (“Riskified”), a fraud management platform enabling frictionless eCommerce, today announced the pricing of its initial public offering of 17,500,000 Class A ordinary shares at a public offering price of $21.00 per Class A ordinary share. The offering consists of 17,300,000 Class A ordinary shares offered by Riskified and 200,000 Class A ordinary shares to be sold by one of Riskified’s existing shareholders. Riskified will not receive any proceeds from the sale of the shares by the selling shareholder. The underwriters will have a 30-day option to purchase up to an additional 2,625,000 Class A ordinary shares from Riskified at the initial public offering price, less underwriting discounts and commissions. The Class A ordinary shares are expected to begin trading on the New York Stock Exchange on July 29, 2021 under the ticker symbol “RSKD”. The closing of the offering is expected to occur on August 2, 2021 subject to the satisfaction of customary closing conditions. Goldm

IFF Appoints Nicolas Mirzayantz President of IFF’s Nourish Division28.7.2021 22:00:00 CEST | Press release

IFF (NYSE: IFF) today announced that Nicolas Mirzayantz, current President, Scent, has been appointed President of IFF’s Nourish division, effective September 1, 2021. Mr. Mirzayantz will succeed Kathy Fortmann, current President, Nourish, who has decided to pursue other opportunities outside of IFF. IFF veteran and current President, Global Consumer Fragrances, Christophe de Villeplee, will assume transition into the role of President, Scent. “We could not be more pleased to have Nicolas lead our Nourish division,” said IFF Chairman and CEO, Andreas Fibig. “Nicolas is joining a Nourish division with a tremendous opportunity to build on significant sales momentum and strong customer interest in IFF’s differentiated portfolio and capabilities. He has been an invaluable member of our leadership team, with an unparalleled ability to create a culture of innovation and deliver creative and winning solutions to our customers while consistently strengthening the business through growth and ma